Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness

JAMA Netw Open. 2022 Jul 1;5(7):e2224172. doi: 10.1001/jamanetworkopen.2022.24172.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antipsychotic Agents* / therapeutic use
  • Cognition
  • Delayed-Action Preparations / therapeutic use
  • Humans
  • Schizophrenia* / drug therapy

Substances

  • Antipsychotic Agents
  • Delayed-Action Preparations